Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale Chief Business Officer sold 75,000 shares at $37.95 ($2,846,310)
  4. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $37.78 ($472,252)
  5. 4 Open-market sale CFO sold 20,000 shares at an average $38.92 ($778,399)
  6. 4 Open-market sale CFO sold 30,000 shares at $50.00 ($1,500,000)
  7. 4 Open-market sale EVP, Research & CSO sold 14,920 shares at an average $44.64 ($666,058)
  8. 4 Open-market sale CFO sold 10,000 shares at $40.00 ($400,000)
  9. 4 Open-market sale EVP, Research & CSO sold 3,510 shares at an average $38.00 ($133,384)
  10. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $37.27 ($465,815)
  11. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $36.28 ($138,030)
  12. 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $35.07 ($438,387)
  13. 4 Open-market sale Chief Business Officer sold 75,000 shares at $35.22 ($2,641,410)
  14. 4 Open-market sale CFO sold 10,000 shares at an average $35.10 ($351,038)
  15. 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $34.08 ($129,674)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 22 of 25 · 491 filings